Cargando…

Effects of probiotic Bifidobacterium bifidum G9‐1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open‐label, single‐arm, exploratory research trial

AIMS/INTRODUCTION: Metformin is associated with the risk of gastrointestinal complications, and probiotic Bifidobacterium bifidum G9‐1 (BBG9‐1) can improve the symptoms of diarrhea. This study aimed to clarify the effects of probiotic BBG9‐1 on the gastrointestinal symptoms of type 2 diabetes mellit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hata, Shinnosuke, Nakajima, Hanako, Hashimoto, Yoshitaka, Miyoshi, Tomoki, Hosomi, Yukako, Okamura, Takuro, Majima, Saori, Nakanishi, Naoko, Senmaru, Takafumi, Osaka, Takafumi, Okada, Hiroshi, Ushigome, Emi, Hamaguchi, Masahide, Asano, Mai, Yamazaki, Masahiro, Fukui, Michiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902400/ https://www.ncbi.nlm.nih.gov/pubmed/34665938 http://dx.doi.org/10.1111/jdi.13698

Ejemplares similares

Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study)
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Reasons for Discontinuing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes in Real-World Settings: The KAMOGAWA-A Study
por: Saijo, Yuto, et al.
Publicado: (2023)

The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study
por: Hosomi, Yukako, et al.
Publicado: (2021)

Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Low circulating arachidonic acid is associated with macroalbuminuria in diabetic patients: a cross-sectional examination of the KAMOGAWA-DM cohort study
por: Okamura, Takuro, et al.
Publicado: (2021)

Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice
por: Hata, Shinnosuke, et al.
Publicado: (2022)

Milk protects against sarcopenic obesity due to increase in the genus Akkermansia in faeces of db/db mice
por: Okamura, Takuro, et al.
Publicado: (2023)

Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study
por: Kitae, Aya, et al.
Publicado: (2020)

Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance
por: Okamura, Takuro, et al.
Publicado: (2021)

Inulin reduces visceral adipose tissue mass and improves glucose tolerance through altering gut metabolites
por: Nakajima, Hanako, et al.
Publicado: (2022)

Effect of COVID-19 Pandemic on the Change in Skeletal Muscle Mass in Older Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Hasegawa, Yuka, et al.
Publicado: (2021)

Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
por: Bamba, Ryo, et al.
Publicado: (2021)

Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes
por: Takegami, Maya, et al.
Publicado: (2022)

Erythritol Ameliorates Small Intestinal Inflammation Induced by High-Fat Diets and Improves Glucose Tolerance
por: Kawano, Rena, et al.
Publicado: (2021)

The Association of Salt Intake and Non-alcoholic Fatty Liver Disease in People With Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2022)

Dietary Fiber Intake Is Related to Skeletal Muscle Mass, Body Fat Mass, and Muscle-to-Fat Ratio Among People With Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2022)

Impact of Eating Speed on Muscle Mass in Older Patients With Type 2 Diabetes: A Prospective Study of KAMOGAWA–DM Cohort
por: Kobayashi, Genki, et al.
Publicado: (2022)

Characterization of Peripheral Blood TCR in Patients with Type 1 Diabetes Mellitus by BD Rhapsody(TM) VDJ CDR3 Assay
por: Okamura, Takuro, et al.
Publicado: (2022)

Japanese radio calisthenics prevents the reduction of skeletal muscle mass volume in people with type 2 diabetes
por: Kimura, Tomonori, et al.
Publicado: (2020)

Let-7e-5p Regulates IGF2BP2, and Induces Muscle Atrophy
por: Okamura, Takuro, et al.
Publicado: (2021)

Leucine and Glutamic Acid as a Biomarker of Sarcopenic Risk in Japanese People with Type 2 Diabetes
por: Nakajima, Hanako, et al.
Publicado: (2023)

Eating Speed Is Associated with the Presence of Sarcopenia in Older Patients with Type 2 Diabetes: A Cross-Sectional Study of the KAMOGAWA-DM Cohort
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

ILC2s Improve Glucose Metabolism Through the Control of Saturated Fatty Acid Absorption Within Visceral Fat
por: Okamura, Takuro, et al.
Publicado: (2021)

Sarcopenia Is Associated With a Risk of Mortality in People With Type 2 Diabetes Mellitus
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Oral Exposure to Polystyrene Microplastics of Mice on a Normal or High-Fat Diet and Intestinal and Metabolic Outcomes
por: Okamura, Takuro, et al.
Publicado: (2023)

Association between the frequency of toothbrushing and lifestyle in people with type 2 diabetes mellitus: at the baseline date of the Kamogawa-DM cohort study
por: Saijo, Yuto, et al.
Publicado: (2021)

Usefulness of Exercise for Home Blood Pressure Control in People with Diabetes: A Study Protocol for a Crossover Randomized Controlled Trial
por: Iwai, Keiko, et al.
Publicado: (2020)

Effects of Royal Jelly on Gut Dysbiosis and NAFLD in db/db Mice
por: Kobayashi, Genki, et al.
Publicado: (2023)

Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study
por: Hamaguchi, Masahide, et al.
Publicado: (2022)

Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with a Low Prevalence of Sarcopenia in Patients with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2020)

Association between Geriatric Nutrition Risk Index and The Presence of Sarcopenia in People with Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with Glycemic Variability in Patients with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Dental care and oral conditions are associated with the prevalence of sarcopenia in people with type 2 diabetes: a cross-sectional study
por: Takahashi, Fuyuko, et al.
Publicado: (2023)

Usefulness of Aerobic Exercise for Home Blood Pressure Control in Patients with Diabetes: Randomized Crossover Trial
por: Iwai, Keiko, et al.
Publicado: (2022)

Association of Estimated Salt and Miso Intake with the Prevalence of Obesity in People with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Household Income Is Related to Dietary Fiber Intake and Dietary Acid Load in People with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2022)

Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes
por: Takewaki, Fumie, et al.
Publicado: (2021)

Vitamin Intake and Loss of Muscle Mass in Older People with Type 2 Diabetes: A Prospective Study of the KAMOGAWA-DM Cohort
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity
por: Okamura, Takuro, et al.
Publicado: (2022)

Impact of extracellular‐to‐intracellular fluid volume ratio on albuminuria in patients with type 2 diabetes: A cross‐sectional and longitudinal cohort study
por: Nakajima, Hanako, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3em1hpp1eo5i3sffui5dspkqju